Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bristol-Myers Squibb Company ROUTE 206 AND PROVINCE LINE ROAD PRINCETON NJ 08543 USA

www.bms.com P: 609-252-4621

Description:

Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.

Key Statistics

Overview:

Market Capitalization, $K 97,892,464
Enterprise Value, $K 126,200,464
Shares Outstanding, K 2,026,759
Annual Sales, $ 45,006 M
Annual Net Income, $ 8,025 M
Last Quarter Sales, $ 11,477 M
Last Quarter Net Income, $ 1,762 M
EBIT, $ 17,487 M
EBITDA, $ 27,247 M
60-Month Beta 0.39
% of Insider Shareholders 0.09%
% of Institutional Shareholders 76.41%
Float, K 2,024,935
% Float 99.91%
Short Volume Ratio 0.37

Growth:

1-Year Return -31.23%
3-Year Return -26.83%
5-Year Return 5.25%
5-Year Revenue Growth 99.49%
5-Year Earnings Growth 88.69%
5-Year Dividend Growth 42.50%

Per-Share Information:

Most Recent Earnings 1.70 on 02/02/24
Latest Earnings Date 04/25/24 [BMO]
Earnings Per Share ttm 7.50
EPS Growth vs. Prev Qtr -15.00%
EPS Growth vs. Prev Year -6.59%
Annual Dividend Rate, $ 2.34
Annual Dividend Yield 4.84%
Most Recent Dividend 0.600 on 04/04/24
Next Ex-Dividends Date 04/04/24
Dividend Payable Date 05/01/24
Dividend Payout Ratio 30.18%
Most Recent Split 2-1 on 03/01/99

BMY Ratios

Ratio
Price/Earnings ttm 6.38
Price/Earnings forward 7.32
Price/Earnings to Growth 1.46
Return-on-Equity % 50.95%
Return-on-Assets % 16.67%
Profit Margin % 17.83%
Debt/Equity 1.35
Price/Sales 2.15
Price/Cash Flow 3.89
Price/Book 3.35
Book Value/Share 14.49
Interest Coverage 2.28

BMY Dividends

Date Value
04/04/24 $0.6000
01/04/24 $0.6000
10/05/23 $0.5700
07/06/23 $0.5700
04/06/23 $0.5700
01/05/23 $0.5700
10/06/22 $0.5400
06/30/22 $0.5400
03/31/22 $0.5400
01/06/22 $0.5400
09/30/21 $0.4900
07/01/21 $0.4900
03/31/21 $0.4900
12/31/20 $0.4900
10/01/20 $0.4500
07/02/20 $0.4500
04/02/20 $0.4500
01/02/20 $0.4500
10/03/19 $0.4100
07/03/19 $0.4100
04/04/19 $0.4100
01/03/19 $0.4100
10/04/18 $0.4000
07/05/18 $0.4000
04/05/18 $0.4000
01/04/18 $0.4000
10/05/17 $0.3900
07/05/17 $0.3900
04/05/17 $0.3900
01/04/17 $0.3900
10/05/16 $0.3800
06/29/16 $0.3800
03/30/16 $0.3800
12/30/15 $0.3800
09/30/15 $0.3700
07/01/15 $0.3700
04/01/15 $0.3700
12/30/14 $0.3700
10/01/14 $0.3600
07/01/14 $0.3600
04/02/14 $0.3600
12/31/13 $0.3600
10/02/13 $0.3500
07/02/13 $0.3500
04/03/13 $0.3500
01/02/13 $0.3500
10/03/12 $0.3400
07/03/12 $0.3400
04/03/12 $0.3400
01/04/12 $0.3400
10/06/11 $0.3300
06/29/11 $0.3300
03/30/11 $0.3300
01/05/11 $0.3300
09/29/10 $0.3200
06/30/10 $0.3200
03/30/10 $0.3200
12/30/09 $0.3200
09/30/09 $0.3100
07/01/09 $0.3100
04/01/09 $0.3100
12/30/08 $0.3100
10/01/08 $0.3100
07/02/08 $0.3100
04/02/08 $0.3100
01/02/08 $0.3100
10/03/07 $0.2800
07/03/07 $0.2800
04/03/07 $0.2800
01/03/07 $0.2800
10/04/06 $0.2800
07/05/06 $0.2800
04/05/06 $0.2800
01/04/06 $0.2800
10/05/05 $0.2800
06/29/05 $0.2800
03/30/05 $0.2800
01/05/05 $0.2800
09/29/04 $0.2800
06/30/04 $0.2800
03/31/04 $0.2800
12/30/03 $0.2800
10/01/03 $0.2800
07/01/03 $0.2800
04/02/03 $0.2800
12/31/02 $0.2800
10/02/02 $0.2800
07/02/02 $0.2800
04/03/02 $0.2800
01/02/02 $0.2800
10/03/01 $0.2750
08/07/01 $2.7800
07/03/01 $0.2750
04/04/01 $0.2750
01/03/01 $0.2750
10/04/00 $0.2450
06/30/99 $0.2160
03/30/99 $0.2150
01/06/99 $0.2150
09/30/98 $0.1950
06/30/98 $0.1950
04/01/98 $0.1950
12/30/97 $0.1950
10/01/97 $0.1900
07/01/97 $0.1900
04/02/97 $0.1900
12/31/96 $0.1900
10/02/96 $0.1875
07/02/96 $0.1875
04/02/96 $0.1875
01/03/96 $0.1875
10/04/95 $0.1850
07/05/95 $0.1850
04/03/95 $0.1850
12/30/94 $0.1850
10/03/94 $0.1825
06/27/94 $0.1825
03/25/94 $0.1825
01/03/94 $0.1825
09/27/93 $0.1800
06/28/93 $0.1800
03/29/93 $0.1800
01/04/93 $0.1800
09/28/92 $0.1725
06/26/92 $0.1725
03/30/92 $0.1725
12/27/91 $0.1725
09/30/91 $0.1500
06/28/91 $0.1500
04/01/91 $0.1500
12/28/90 $0.1500
10/01/90 $0.1325
06/29/90 $0.1325
04/02/90 $0.1325
12/29/89 $0.1325
09/19/89 $0.1250
06/30/89 $0.1250
04/03/89 $0.1250
12/30/88 $0.1250
10/03/88 $0.1050
06/27/88 $0.1050
03/25/88 $0.1050
01/04/88 $0.1050
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar